Antabuse moves into clinical trial for people with RP
Disulfiram (Antabuse), FDA-approved for deterring alcohol, is in a phase 1 trial at the University of Washington to improve vision in retinitis pigmentosa.
Search
Search results
e-Newsletter September 2024
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Information and support
Are you affected by inherited sight loss? We are here to help.
Meet our community: Rachael Foley
Rachael first noticed she had sight problems at the age of 15. She went to her local eye clinic, who said she had an astigmatism.
Make a referral
If you support someone with inherited sight loss and they need additional support or information, you can make a referral to one or more of our dedicated services.
Wedding Fundraising
Find out how you can mark your special day while fundraising for people with inherited sight loss.
Hope for the future
In this article, we hear Colin's story and the reasons why he has hope for the future.
Virtual delegate bag
A virtual delegate bag for our online attendees - Professionals' Conference 2024
Meet a researcher: Chloe Brotherton
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
Podcast: The Blind Poet, Dave Steele
Our West Yorkshire peer support group recently welcomed The Blind Poet, Dave Steele, who is living with retinitis pigmentosa, to their meeting. He talks candidly about his diagnosis, his poetry and his optimistic mindset.